Allurion Technologies Warrants (ALUR.WS)

• Market cap: $200K
• 1 day: 7.35%
• 5 days: -16.00%
• 1 month: 16.26%
• 3 months: -24.83%
• 6 months: -16.00%
• Year to date: -3.72%
• 1 year: -84.00%
• 5 years: -96.77%
• 10 years: -96.77%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Employees: 137

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.54% less ownership

Funds ownership: 6.35% [Q4 2024] → 5.81% (-0.54%) [Q1 2025]

13% less funds holding

Funds holding: 38 [Q4 2024] → 33 (-5) [Q1 2025]

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

58% less capital invested

Capital invested by funds: $601K [Q4 2024] → $253K (-$349K) [Q1 2025]